Gilead Sciences, Inc

Iconic Profile

Gilead Sciences, Inc. (GILD) is a leading biotechnology company focused on the discovery, development, and commercialization of innovative therapeutics in areas of unmet medical need, particularly in antiviral treatments for HIV, hepatitis B, hepatitis C, and influenza, as well as oncology and inflammatory diseases. With a market capitalization of $161.8 billion, Gilead holds a strong position in the healthcare sector, driven by its robust pipeline and established portfolio of antiviral therapies. The company's commitment to advancing science and improving patient outcomes makes it a significant player in the biotechnology landscape, contributing to public health advancements and addressing critical healthcare challenges globally. Gilead's strategic focus on research and development, along with its collaborations and partnerships, further enhances its ability to deliver impactful solutions in the evolving healthcare market.